TABLE 3.
Rechallenge regimen | Participants |
|
---|---|---|
n | % | |
RIF → INH → PZA†‡ | 38 | 50 |
INH → RIF → PZA | 6 | 8 |
RIF → INH | 26 | 30 |
INH → RIF | 4 | 5 |
RIF → PZA | 1 | 1 |
INH → PZA | 1 | 1 |
RIF | 3 | 5 |
INH, isoniazid; PZA, pyrazinamide; RIF, rifampicin.
, One participant was rechallenged with RIF and INH concomitantly, followed by PZA.
, One participant was rechallenged with RIF, PZA and INH concomitantly.